Search research articles
Contact Us
Filters
Showing results (161-170 of 251) with videos related to
Page
of 26
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 1, 1997
Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidant
K Osaka, V B Ritov, J F Bernardo, et al.
The Journal of Laboratory and Clinical Medicine
|
November 1, 1983
Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver
R A Branch, R Cotham, R Johnson, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 1998
Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6
A Adedoyin, P A Arns, W O Richards, et al.
Biochemical Pharmacology
|
January 1, 1978
Impaired drug metabolism in experimental cirrhosis in the rat
J P Villeneuve, A J Wood, D G Shand, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1989
Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities
S A Ward, T Walle, U K Walle, et al.
British Medical Journal
|
January 30, 1971
Incidence of uraemia and requirements for maintenance haemodialysis
R A Branch, G W Clark, A L Cochrane, et al.
British Journal of Clinical Pharmacology
|
August 1, 1975
A relationship between plasma uric acid concentration and the apparent response to frusemide in normal subjects
L E Ramsay, M J Tidd, R M Auty, et al.
British Journal of Clinical Pharmacology
|
October 1, 1977
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]
R A Branch, D M Kornhauser, D G Shand, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1982
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects
E K Jackson, R P Goodman, G A Fitzgerald, et al.
Clinical Pharmacokinetics
|
November 1, 1978
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration
A J Wood, D M Kornhauser, G R Wilkinson, et al.
Page
of 26
Search research articles
Search
Showing results (161-170 of 251) with videos related to
Sort By:
Page
of 26
Antimicrobial Agents and Chemotherapy
|
April 1, 1997
Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidant
K Osaka, V B Ritov, J F Bernardo, et al.
The Journal of Laboratory and Clinical Medicine
|
November 1, 1983
Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver
R A Branch, R Cotham, R Johnson, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 1998
Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6
A Adedoyin, P A Arns, W O Richards, et al.
Biochemical Pharmacology
|
January 1, 1978
Impaired drug metabolism in experimental cirrhosis in the rat
J P Villeneuve, A J Wood, D G Shand, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1989
Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities
S A Ward, T Walle, U K Walle, et al.
British Medical Journal
|
January 30, 1971
Incidence of uraemia and requirements for maintenance haemodialysis
R A Branch, G W Clark, A L Cochrane, et al.
British Journal of Clinical Pharmacology
|
August 1, 1975
A relationship between plasma uric acid concentration and the apparent response to frusemide in normal subjects
L E Ramsay, M J Tidd, R M Auty, et al.
British Journal of Clinical Pharmacology
|
October 1, 1977
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]
R A Branch, D M Kornhauser, D G Shand, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1982
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects
E K Jackson, R P Goodman, G A Fitzgerald, et al.
Clinical Pharmacokinetics
|
November 1, 1978
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration
A J Wood, D M Kornhauser, G R Wilkinson, et al.
Page
of 26